IKENA ONCOLOGY INC (IKNA)
Institutional ownership reported to the SEC as of Q2 2025, across 18 quarters.
40
Reporting holders
$42.3M
Reported value
0.0%
Held as options
-5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | $6.7M | 5,018,178 | 1.02% | 15q | HELD |
| Blue Owl Capital Holdings LP | $5.5M | 4,091,118 | 1.77% | 7q | HELD |
| BML Capital Management, LLC | $5.4M | 4,030,102 | 4.09% | 5q | +8.6%+$427.9K |
| BVF INC/IL | $5.4M | 4,006,564 | 0.19% | 18q | HELD |
| ORBIMED ADVISORS LLC | $4.7M | 3,539,358 | 0.12% | 18q | HELD |
| Deep Track Capital, LP | $3.4M | 2,515,513 | 0.11% | 2q | HELD |
| Omega Fund Management, LLC | $3.0M | 2,249,123 | 1.95% | 18q | HELD |
| VANGUARD GROUP INC | $1.9M | 1,413,649 | 0.00% | 18q | +2.2%+$40.5K |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $1.1M | 800,000 | 0.00% | 9q | HELD |
| NEA Management Company, LLC | $804.1K | 600,063 | 0.06% | 8q | HELD |
| Sofinnova Investments, Inc. | $512.7K | 382,616 | 0.03% | 8q | HELD |
| BlackRock, Inc. | $479.6K | 357,936 | 0.00% | 4q | +2.7%+$12.5K |
| GILEAD SCIENCES, INC. | $467.1K | 348,534 | 0.04% | 3q | -69.9%-$1.1M |
| RENAISSANCE TECHNOLOGIES LLC | $413.9K | 308,856 | 0.00% | 6q | +4.9%+$19.3K |
| GEODE CAPITAL MANAGEMENT, LLC | $412.8K | 307,972 | 0.00% | 17q | -2.9%-$12.2K |
| Aldebaran Capital, LLC | $324.4K | 242,116 | 0.32% | 2q | -2.3%-$7.6K |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $265.5K | 198,107 | 0.00% | 10q | -19.3%-$63.5K |
| CITADEL ADVISORS LLC | $212.0K | 158,215 | 0.00% | 18q | +98.5%+$105.2K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $205.4K | 153,300 | 0.00% | 13q | HELD |
| TWO SIGMA ADVISERS, LP | $193.1K | 144,100 | 0.00% | 6q | -4.8%-$9.8K |
| STATE STREET CORP | $123.5K | 92,153 | 0.00% | 17q | HELD |
| Squarepoint Ops LLC | $113.5K | 84,680 | 0.00% | 3q | +9.4%+$9.7K |
| UBS Group AG | $100.0K | 74,661 | 0.00% | 10q | -25.8%-$34.8K |
| GOLDMAN SACHS GROUP INC | $89.3K | 66,664 | 0.00% | 10q | -12.8%-$13.1K |
| BARCLAYS PLC | $88.7K | 66,177 | 0.00% | 14q | HELD |
| TWO SIGMA INVESTMENTS, LP | $79.0K | 58,957 | 0.00% | 8q | -25.8%-$27.4K |
| NORTHERN TRUST CORP | $77.1K | 57,565 | 0.00% | 17q | HELD |
| MILLENNIUM MANAGEMENT LLC | $66.1K | 49,315 | 0.00% | 5q | -29.2%-$27.3K |
| DIMENSIONAL FUND ADVISORS LP | $51.8K | 38,621 | 0.00% | 13q | HELD |
| Royal Bank of Canada | $42.0K | 32,000 | 0.00% | new | NEW |
| MORGAN STANLEY | $36.7K | 27,416 | 0.00% | 17q | +118.1%+$19.9K |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | $26.8K | 20,000 | 0.00% | 5q | HELD |
| XTX Topco Ltd | $22.8K | 16,999 | 0.00% | 3q | -69.9%-$52.9K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $17.6K | 13,141 | 0.00% | new | NEW |
| Tower Research Capital LLC (TRC) | $3.0K | 2,275 | 0.00% | new | NEW |
| JPMORGAN CHASE & CO | $1.1K | 849 | 0.00% | 17q | HELD |
| BANK OF AMERICA CORP /DE/ | $733 | 547 | 0.00% | 17q | +147.5% |
| WELLS FARGO & COMPANY/MN | $670 | 500 | 0.00% | new | NEW |
| BNP PARIBAS FINANCIAL MARKETS | $422 | 315 | 0.00% | 3q | HELD |
| ACADIAN ASSET MANAGEMENT LLC | $278 | 209,568 | 0.00% | 13q | HELD |
| SBI Securities Co., Ltd. | $4 | 3 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 40 | $42.3M | 31,568,258 | 4 | 8 | 10 | 0.0% |
| Q1 2025 | 45 | $41.6M | 32,538,102 | 3 | 7 | 17 | 0.0% |
| Q4 2024 | 52 | $51.5M | 31,422,537 | 4 | 9 | 18 | 0.0% |
| Q3 2024 | 55 | $48.2M | 27,851,320 | 4 | 11 | 18 | 0.0% |
| Q2 2024 | 66 | $47.2M | 28,627,639 | 25 | 12 | 18 | 0.0% |
| Q1 2024 | 52 | $41.4M | 29,137,447 | 10 | 14 | 13 | 0.0% |
| Q4 2023 | 49 | $61.9M | 31,407,233 | 5 | 25 | 9 | 0.0% |
| Q3 2023 | 52 | $133.3M | 30,814,349 | 7 | 25 | 7 | 0.0% |
| Q2 2023 | 48 | $192.4M | 29,322,106 | 15 | 17 | 7 | 0.0% |
| Q1 2023 | 35 | $91.9M | 26,624,865 | 7 | 16 | 4 | 0.0% |
| Q4 2022 | 26 | $64.9M | 24,408,390 | 0 | 6 | 6 | 0.0% |
| Q3 2022 | 41 | $97.8M | 27,545,425 | 6 | 16 | 7 | 0.0% |
| Q2 2022 | 42 | $118.7M | 26,785,933 | 12 | 5 | 17 | 0.0% |
| Q1 2022 | 48 | $167.8M | 27,490,282 | 8 | 13 | 14 | 0.0% |
| Q4 2021 | 49 | $343.7M | 27,405,058 | 12 | 24 | 4 | 0.0% |
| Q3 2021 | 39 | $271.8M | 20,880,074 | 2 | 20 | 8 | 0.0% |
| Q2 2021 | 42 | $293.2M | 21,065,019 | 22 | 8 | 3 | 0.0% |
| Q1 2021 | 27 | $538.5M | 19,313,430 | 27 | 0 | 0 | 0.0% |